- Home
- CUE vs VCSA Comparison
CUE vs VCSA Comparison
Compare CUE & VCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- VCSA
- Stock Information
- Founded
- CUE 2014
- VCSA 2009
- Country
- CUE United States
- VCSA United States
- Employees
- CUE N/A
- VCSA N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- VCSA Computer Software: Prepackaged Software
- Sector
- CUE Health Care
- VCSA Technology
- Exchange
- CUE Nasdaq
- VCSA Nasdaq
- Market Cap
- CUE 37.0M
- VCSA 34.5M
- IPO Year
- CUE 2018
- VCSA N/A
- Fundamental
- Price
- CUE $0.59
- VCSA $3.34
- Analyst Decision
- CUE Strong Buy
- VCSA Buy
- Analyst Count
- CUE 5
- VCSA 4
- Target Price
- CUE $5.00
- VCSA $7.50
- AVG Volume (30 Days)
- CUE 221.5K
- VCSA 106.8K
- Earning Date
- CUE 11-01-2024
- VCSA 11-05-2024
- Dividend Yield
- CUE N/A
- VCSA N/A
- EPS Growth
- CUE N/A
- VCSA N/A
- EPS
- CUE N/A
- VCSA N/A
- Revenue
- CUE $8,295,000.00
- VCSA $1,014,965,000.00
- Revenue This Year
- CUE $104.90
- VCSA $42.67
- Revenue Next Year
- CUE N/A
- VCSA N/A
- P/E Ratio
- CUE N/A
- VCSA N/A
- Revenue Growth
- CUE 363.67
- VCSA N/A
- 52 Week Low
- CUE $0.56
- VCSA $2.07
- 52 Week High
- CUE $3.25
- VCSA $13.00
- Technical
- Relative Strength Index (RSI)
- CUE 35.76
- VCSA 49.28
- Support Level
- CUE $0.58
- VCSA $3.14
- Resistance Level
- CUE $0.70
- VCSA $3.59
- Average True Range (ATR)
- CUE 0.09
- VCSA 0.35
- MACD
- CUE -0.00
- VCSA 0.07
- Stochastic Oscillator
- CUE 6.29
- VCSA 69.85
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About VCSA Vacasa Inc.
Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.